Carotid artery stenosis treatment — the endarterectomy versus carotid artery stenting debate that has evolved over three decades with robust randomized trial evidence guiding the appropriate role for endovascular carotid treatment — creates the carotid intervention market where device innovation and clinical evidence intersect, with the Peripheral Angioplasty Market reflecting carotid intervention as a significant peripheral market segment.

CREST-2 registry and carotid stenting evidence — the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) comparing carotid artery stenting (CAS) versus carotid endarterectomy (CEA) for symptomatic and asymptomatic carotid stenosis — defined the appropriate CAS versus CEA patient selection. CREST's primary endpoint finding of equivalent combined stroke, MI, and death between CAS and CEA with age-dependent outcomes (CAS favored in younger patients, CEA favored in older patients) has shaped carotid intervention guidelines.

Transcarotid artery revascularization (TCAR) — the TransCarotid Artery Revascularization procedure providing a hybrid endovascular approach with direct carotid artery access, flow reversal for cerebral protection during stenting, and carotid stent deployment — represents the innovative carotid intervention approach addressing the higher stroke rate with transfemoral carotid stenting. Silk Road Medical's ENROUTE TCAR system using direct surgical carotid access with flow reversal provides the cerebral embolic protection that transfemoral stenting with filter wires cannot match for certain anatomically challenging patients.

Drug-coated balloon for carotid in-stent restenosis — the emerging application of drug-coated balloons for carotid in-stent restenosis treatment — represents the peripheral DCB application extension to the carotid circulation as an alternative to repeat carotid stenting or surgical endarterectomy after prior carotid stent placement.

Do you think TCAR represents a genuine advance in carotid intervention safety compared to transfemoral carotid stenting, or is it primarily appropriate for patients with hostile surgical anatomy who would otherwise be poor CEA candidates?

FAQ

What is TCAR and when is it indicated? Transcarotid Artery Revascularization (TCAR) is an FDA-approved hybrid carotid revascularization procedure; access is through a two-centimeter neck incision directly onto the common carotid artery; the ENROUTE system creates flow reversal (carotid blood redirected from artery through filter to femoral vein) protecting the brain from emboli during stent deployment; after flow reversal established, guidewire crossing and carotid stent deployment performed; following stent delivery, flow reversal discontinued and flow restored; main indications: symptomatic carotid stenosis in patients at high surgical risk for CEA (severe coronary disease, recent MI, contralateral carotid occlusion, prior neck surgery/radiation, hostile neck anatomy); represents improvement over standard CAS for high-surgical-risk patients by reducing stroke risk compared to transfemoral CAS while avoiding open surgical endarterectomy risks.

What are carotid artery stents and how are they deployed? Carotid artery stents are self-expanding nitinol mesh tubes deployed in the carotid artery to treat stenosis; transfemoral approach: guidewire access from femoral artery, cervical carotid artery catheterization, cerebral embolic protection device (filter or flow reversal) placed across the lesion before stenting, pre-dilation optional, stent deployment across stenosis, post-dilation of stent to achieve optimal expansion; carotid stents are specifically designed with appropriate cell size to cover irregular plaque without excessive membrane covering branches, appropriate flexibility for carotid anatomy, good radial force; FDA-approved systems: Medtronic Protégé, Abbott Xact, iVascular Cristallo; high-surgical-risk indication per FDA (symptomatic greater than seventy percent or asymptomatic greater than eighty percent in high-surgical-risk patients).

#PeripheralAngioplasty #CarotidStenting #TCAR #CarotidIntervention #CEAvsCarotidStenting #CarotidArtery